We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

112 hedge funds and large institutions have $123M invested in VanEck Biotech ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $2.41M | Put options by funds: $1.19M

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

2.21% more ownership

Funds ownership: 33.22% → 35.44% (+2.2%)

1% more funds holding

Funds holding: 111 → 112 (+1)

1% less capital invested

Capital invested by funds: $125M → $123M (-$1.86M)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
112
Holders Change
+1
Holders Change %
+0.9%
% of All Funds
1.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
16
Increased
21
Reduced
25
Closed
12
Calls
$2.41M
Puts
$1.19M
Net Calls
+$1.22M
Net Calls Change
+$2.75M

Top Buyers

Rank Fund Capital Flow
1
AA
Ascent Advisors
Minnesota
+$11.5M
2
Bank of America
Bank of America
North Carolina
+$3.93M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.83M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$729K
5
Wells Fargo
Wells Fargo
California
+$667K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.03M
2
Corient Private Wealth
Corient Private Wealth
Florida
-$1.9M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
4
LPL Financial
LPL Financial
California
-$1.01M
5
UBS Group
UBS Group
Switzerland
-$690K
Name Holding Trade Value Shares
Change 		Change in
Stake
CB
51
Commerce Bank
Missouri
$244K – – –
CWP
52
Cyndeo Wealth Partners
Florida
$244K – – –
Cambridge Investment Research Advisors
53
Cambridge Investment Research Advisors
Iowa
$239K -$39.1K -203 -14%
Creative Planning
54
Creative Planning
Kansas
$235K -$27.4K -142 -10%
Citigroup
55
Citigroup
New York
$234K +$240K +1,246 New
PAG
56
Private Advisor Group
New Jersey
$216K – – –
FFG
57
Forum Finance Group
$215K +$278K +1,445 New
GAM
58
Gotham Asset Management
New York
$215K +$220K +1,143 New
CIBC World Market
59
CIBC World Market
Ontario, Canada
$209K -$12.3K -64 -5%
PTC
60
Philadelphia Trust Company
Pennsylvania
$207K – – –
FFN
61
Focus Financial Network
Minnesota
$204K – – –
Corient Private Wealth
62
Corient Private Wealth
Florida
$204K -$1.9M -9,881 -90%
IWC
63
Integrated Wealth Concepts
Massachusetts
$203K +$208K +1,082 New
EPAM
64
Evelyn Partners Asset Management
$177K – – –
UB
65
UMB Bank
Missouri
$169K – – –
Osaic Holdings
66
Osaic Holdings
Arizona
$164K -$2.7K -14 -2%
Northwestern Mutual Wealth Management
67
Northwestern Mutual Wealth Management
Wisconsin
$161K -$62.6K -325 -28%
WSFS
68
Wilmington Savings Fund Society
Delaware
$150K – – –
HNB
69
Huntington National Bank
Ohio
$132K – – –
Fifth Third Bancorp
70
Fifth Third Bancorp
Ohio
$127K +$130K +675 New
IF
71
Integrity Financial
Wyoming
$125K +$128K +664 New
Belvedere Trading
72
Belvedere Trading
Illinois
$114K +$117K +606 New
FFA
73
Farther Finance Advisors
California
$92K +$54.9K +285 +142%
AF
74
Allworth Financial
California
$80.1K – – –
LFASL
75
Lugano Financial Advisors SA (LFA)
Switzerland
$58.3K – – –
1 2
3
4 5

BBH Hedge Fund Activity: Q1 2026 in Review

112 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2026, worth a combined $123M — down 1.5% from $125M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 12 closed out — a net gain of 4 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was Ascent Advisors, opening a new position worth an estimated $11.5M. The largest seller was Morgan Stanley, cutting an estimated $5.03M.

  • 112 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2026, up from 111 in Q4 2025.
  • Funds reported $123M of VanEck Biotech ETF stock for Q1 2026, down 1.5% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q1 2026 and 12 closed out, a net change of +4 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2026 was Ascent Advisors, an estimated $11.5M added.
  • The largest VanEck Biotech ETF seller in Q1 2026 was Morgan Stanley, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2026.